Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (71-80 of 312) with videos related to

Pageof 32
Sort By:
Urologic Oncology|January 11, 2015
Immunotherapy for castration-resistant prostate cancer: Progress and new paradigmsDavid I Quinn, Neal D Shore, Shin Egawa, et al.
Targeted Oncology|November 18, 2022
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary TeamsNeal D Shore, Alicia K Morgans, Ghassan El-Haddad, et al.
Future Oncology (London, England)|March 7, 2025
The impact of concomitant therapies on the efficacy and safety of relugolix in advanced prostate cancerNeal D Shore, Daniel J George, Daniel E Spratt, et al.
The Journal of Urology|July 22, 2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available TherapiesE David Crawford, Celestia S Higano, Neal D Shore, et al.
Journal of Health Economics and Outcomes Research|May 14, 2021
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic HyperplasiaBilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, et al.
European Urology Focus|April 18, 2026
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysisNeal D Shore, Noman Paracha, Howard Thom, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utilityE David Crawford, Neal D Shore, Daniel P Petrylak, et al.
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Urology|April 1, 2008
Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptomsMartin K Dineen, Neal D Shore, Jeffrey H Lumerman, et al.
Urology Practice|June 20, 2024
Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer PatientsMohamad Abou Chakra, Neal D Shore, Erica S Brown, et al.
Pageof 32

Showing results (71-80 of 312) with videos related to

Sort By:
Pageof 32
Urologic Oncology|January 11, 2015
Immunotherapy for castration-resistant prostate cancer: Progress and new paradigmsDavid I Quinn, Neal D Shore, Shin Egawa, et al.
Targeted Oncology|November 18, 2022
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary TeamsNeal D Shore, Alicia K Morgans, Ghassan El-Haddad, et al.
Future Oncology (London, England)|March 7, 2025
The impact of concomitant therapies on the efficacy and safety of relugolix in advanced prostate cancerNeal D Shore, Daniel J George, Daniel E Spratt, et al.
The Journal of Urology|July 22, 2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available TherapiesE David Crawford, Celestia S Higano, Neal D Shore, et al.
Journal of Health Economics and Outcomes Research|May 14, 2021
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic HyperplasiaBilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, et al.
European Urology Focus|April 18, 2026
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysisNeal D Shore, Noman Paracha, Howard Thom, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utilityE David Crawford, Neal D Shore, Daniel P Petrylak, et al.
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Urology|April 1, 2008
Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptomsMartin K Dineen, Neal D Shore, Jeffrey H Lumerman, et al.
Urology Practice|June 20, 2024
Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer PatientsMohamad Abou Chakra, Neal D Shore, Erica S Brown, et al.
Pageof 32